The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl for the potential treatment of breakthrough pain episodes in patients who have chronic noncancer pain.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
500
Safety and tolerability when used over a 12-month period for the management of breakthrough pain in opioid tolerant patients
Assess the patients' quality of life through questionnaires
Assess the patients' overall medication preferences
Assess the patients' overall medication performance
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
MedSearch
Calera, Alabama, United States
Clinical Research Consultants, Inc.
Hoover, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
NEA Clinic
Jonesboro, Arkansas, United States
Lynn Institute of the Rockies
Colorado Springs, Colorado, United States
Radiant Research-Daytona Beach
Daytona Beach, Florida, United States
Advent Clinical Research Centers, Inc.
St. Petersburg, Florida, United States
Gold Coast Research
Weston, Florida, United States
Center for Prospective Outcome Studies, Inc.
Atlanta, Georgia, United States
Advent Clinical Research Centers, Inc.
Atlanta, Georgia, United States
...and 28 more locations